Author

Serena Pellegatta

Fondazione IRCCS Istituto Neurologico Carlo BestaORCID 0000-0001-7804-9486Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioinformatics· 1 Genetic & Genomic Medicine· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:database / resource· 1 Research Focus:differential expression· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1

Frequent Co-Authors

Dietmar RiederiD· 1 shared Emanuele BonettiiD· 1 shared Francesca FinotelloiD· 1 shared Giorgia LambertiiD· 1 shared Luca MazzarellaiD· 1 shared Manuel Facciolla· 1 shared Marica EoliiD· 1 shared Markus Außerhofer· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioinformatics

Dietmar RiederORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

NovumRNA: accurate prediction of non-canonical tumor antigens from RNA sequencing data

Markus Außerhofer, Dietmar Rieder, Manuel Facciolla, Raphael Gronauer, Giorgia Lamberti, Rebecca Lisandrelli, Serena Pellegatta, Zlatko Trajanoski, Francesca Finotello

NovumRNA predicts non-canonical tumor antigens from RNA sequencing data, showing robustness across cancer types and identifying therapy-induced antigens in glioblastoma.

iScience · Sep 3, 2025Peer-reviewedBioinformatics

RENOVO-NF1 accurately predicts NF1 missense variant pathogenicity

Emanuele Bonetti, Serena Pellegatta, Nayma Rosati, Marica Eoli, Luca Mazzarella

RENOVO-NF1 predicts pathogenicity of NF1 missense variants with high accuracy, reclassifying many variants of unknown significance.

Human Genomics · Aug 31, 2025Peer-reviewedGenetic & Genomic Medicine